U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 214275

UPTRAVI (SELEXIPAG)
1.8MG/VIAL
Marketing Status: Prescription
Active Ingredient: SELEXIPAG
Proprietary Name: UPTRAVI
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: 1.8MG/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N214275
Product Number: 001
Approval Date: Jul 29, 2021
Applicant Holder Full Name: ACTELION PHARMACEUTICALS US INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top